News Conference News AHA 2025 CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI Michael O'Riordan November 11, 2025
News Conference News ACC 2024 Long-Awaited RCT Data Show Survival Benefit With Impella CP: DanGer Shock Caitlin E. Cox April 07, 2024
News Conference News AHA 2023 DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI Shelley Wood November 11, 2023
News Conference News ESC 2023 Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK Caitlin E. Cox August 26, 2023
News Conference News ESC 2023 FIRE: Complete Revascularization Best Even for Elderly Patients With MI Michael O'Riordan August 26, 2023
News Daily News Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees Michael O'Riordan January 05, 2023
News Conference News ESC 2022 DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark L.A. McKeown August 30, 2022
News Conference News ACC 2021 FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI Caitlin E. Cox May 25, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for June 2020 Shelley Wood July 02, 2020
News Daily News COVID-19, ACE Inhibitors, and ARBs: Multiple Studies Show No Increased Risk Michael O'Riordan May 05, 2020
News Features Dire, Unusual STEMI Complications Blamed on COVID-19 Hospital Avoidance Shelley Wood April 29, 2020
News Daily News EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up Michael O'Riordan December 10, 2019
News Conference News Former EXCEL Investigator Alleges Trial Manipulation, Prompting Vehement Denials Michael O'Riordan October 07, 2019
News Conference News ESC 2018 SCOT-HEART: A Win for CT Angiography in Chest Pain Workup Prompts Cacophony of Reactions Shelley Wood August 31, 2018
News Conference News ACC 2017 iFR Matches FFR for Clinical Outcomes in Patients With Intermediate Lesions Caitlin E. Cox March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News Subestudio del COURAGE: La PCI No Ofrece Beneficio Añadido sobre, Solo, el Tratamiento Médico Óptimo, ni en Hombres ni en Mujeres L.A. McKeown August 03, 2015